Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
11 angezeigte Treffer · Seite 3, keine Gesamtzahl für „obinutuzumab“
Suchtreffer
Begriffe & Kennungen
Columvi · 4.3 · For specific contraindications on obinutuzumab, please refer to the obinutuzumab prescribing information.
Eintrag öffnenColumvi · 4.3 · Hypersensitivity to the active substance, to obinutuzumab, or to any of the excipients listed in section 6.1.
Eintrag öffnenGazyvaro · 4.5 · Obinutuzumab is not a substrate, inhibitor, or inducer of cytochrome P450 (CYP450), uridine diphosphate glucur
Eintrag öffnenGazyvaro · 4.5 · The combination of obinutuzumab with chlorambucil, bendamustine, CHOP or CVP may increase the risk of neutrope
Eintrag öffnenGazyvaro · 4.8 · Obinutuzumab treatment resulted in a decrease in total immunoglobulins in pooled LN data from placebo-controll
Eintrag öffnenVenclyxto · 4.8 · AMPLIFY When venetoclax is administered in combination with acalabrutinib with or without obinutuzumab, refer
Eintrag öffnenVenclyxto · 4.8 · In the CLL14 study, neutropenia (all grades) was reported in 58% of patients in the venetoclax + obinutuzumab
Eintrag öffnenVenclyxto · 4.8 · The frequencies of adverse reactions reported with Venclyxto, in combination with obinutuzumab, ibrutinib, or
Eintrag öffnenVenclyxto · 4.8 · The safety of venetoclax in combination with acalabrutinib with or without obinutuzumab was assessed in AMPLIF
Eintrag öffnenobinutuzumab
Eintrag öffnenobinutuzumab
Eintrag öffnen